Spyre Therapeutics Inc.

12.51
0.09 (0.72%)
At close: Apr 17, 2025, 10:44 AM

Spyre Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-208.02M -338.79M -83.81M -65.8M -80.89M -78.25M -44.35M -27.24M -21.7M
-11.4M 744K 1.57M 1.58M 996K 901K 293K 249K 132K
44.83M 25.68M 7.11M 8.04M 6.26M n/a n/a n/a n/a
n/a -5.8M -2.86M 768K -2M 4.52M 3.88M 1.5M 976K
17.18M 217.67M 823K 90K 619K 3.78M 1.93M 4.77M 1.07M
n/a n/a -327K 548K -213K n/a n/a n/a n/a
n/a -5.21M -5.5M 1.83M -2.54M 7.1M 7.2M -198K 1.45M
-157.41M -99.91M -80.14M -53.72M -75.78M -65.69M -32.19M -24.61M -18.84M
n/a n/a -38K -573K -4.28M -1.49M -422K -619K -212K
n/a 3.04M n/a n/a n/a n/a n/a n/a n/a
-599.25M -166.8M -39.5M -133.08M -129M -91.93M -62.18M -64.11M -20.39M
245.97M 39.9M 96.55M 111.03M 125.68M 91.68M 47.37M 42.2M 8.45M
n/a 15.47M n/a n/a n/a n/a n/a n/a n/a
-353.29M -108.39M 57.01M -22.62M -7.6M -1.74M -15.23M -22.53M -12.16M
n/a -16K -418K -510K -20K -25K n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
5.67M -5.38M 222K 1.9M 816K 1.45M 3.02M 833K 76K
410.91M 361.08M 42.68M 1.39M 154.51M 65.72M 57.07M 12.21M 49.37M
-99.79M 152.8M 19.44M -74.96M 71.18M -3.21M 9.64M -34.93M 18.37M
-157.41M -99.91M -80.18M -54.29M -80.06M -67.18M -32.61M -25.23M -19.05M